Immupeutics Medicine Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 8

Immupeutics Medicine General Information

Description

Developer of immune cell therapy drugs for the treatment of tumors. The company focuses on the research and development of companion diagnostic technology and immunological multi-omics technology, aiming to provide patients with innovative immune cell therapy drugs and integrated treatment methods.

Contact Information

Website
www.immupeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 201-2, 2/F, No.2 Building, No.16 BaoShen South Street
  • Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District
  • Beijing, 102609
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 201-2, 2/F, No.2 Building, No.16 BaoShen South Street
  • Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District
  • Beijing, 102609
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immupeutics Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 12-Sep-2023 Completed Clinical Trials - General
2. Early Stage VC 30-Sep-2021 Completed Clinical Trials - General
1. Early Stage VC 29-Jun-2021 Completed Startup
To view Immupeutics Medicine’s complete valuation and funding history, request access »

Immupeutics Medicine Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Shunxi Private Equity Fund Management Growth/Expansion Minority
Junshi Biosciences Corporation Minority
AbogenBio VC-Backed Company Minority
Alwin Capital Venture Capital Minority
Lotus Lake Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Immupeutics Medicine FAQs

  • When was Immupeutics Medicine founded?

    Immupeutics Medicine was founded in 2018.

  • Where is Immupeutics Medicine headquartered?

    Immupeutics Medicine is headquartered in Beijing, China.

  • What industry is Immupeutics Medicine in?

    Immupeutics Medicine’s primary industry is Drug Discovery.

  • Is Immupeutics Medicine a private or public company?

    Immupeutics Medicine is a Private company.

  • What is Immupeutics Medicine’s current revenue?

    The current revenue for Immupeutics Medicine is .

  • How much funding has Immupeutics Medicine raised over time?

    Immupeutics Medicine has raised $15.5M.

  • Who are Immupeutics Medicine’s investors?

    Beijing Shunxi Private Equity Fund Management, Junshi Biosciences, AbogenBio, Alwin Capital, and Lotus Lake Ventures are 5 of 8 investors who have invested in Immupeutics Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process